Denkert C - Search Results

1

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

Denkert C, Loibl S, Noske A, Roller M, Müller BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R, Hanusch C, von Törne C, Weichert W, Engels K, Solbach C, Schrader I, Dietel M, von Minckwitz G. Denkert C, et al. J Clin Oncol. 2010 Jan 1;28(1):105-13. doi: 10.1200/JCO.2009.23.7370. Epub 2009 Nov 16. J Clin Oncol. 2010. PMID: 19917869 Clinical Trial.

2

Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.

Hauptmann S, Denkert C, Koch I, Petersen S, Schlüns K, Reles A, Dietel M, Petersen I. Hauptmann S, et al. Among authors: denkert c. Hum Pathol. 2002 Jun;33(6):632-41. doi: 10.1053/hupa.2002.124913. Hum Pathol. 2002. PMID: 12152163

3

Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.

Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, Lichtenegger W, Dietel M, Hauptmann S. Denkert C, et al. Int J Cancer. 2002 Dec 10;102(5):507-13. doi: 10.1002/ijc.10746. Int J Cancer. 2002. PMID: 12432554

4

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I. Kristiansen G, et al. Among authors: denkert c. Br J Cancer. 2003 Jan 27;88(2):231-6. doi: 10.1038/sj.bjc.6600702. Br J Cancer. 2003. PMID: 12610508 Free PMC article.

5

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Denkert C, et al. Cancer. 2003 Jun 15;97(12):2978-87. doi: 10.1002/cncr.11437. Cancer. 2003. PMID: 12784332 Free article.

6

Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.

Weichert W, Gekeler V, Denkert C, Dietel M, Hauptmann S. Weichert W, et al. Among authors: denkert c. Int J Oncol. 2003 Sep;23(3):633-9. Int J Oncol. 2003. PMID: 12888898

7

CD24 expression is a new prognostic marker in breast cancer.

Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M. Kristiansen G, et al. Among authors: denkert c. Clin Cancer Res. 2003 Oct 15;9(13):4906-13. Clin Cancer Res. 2003. PMID: 14581365

8

Induction of apoptosis in the centre of multicellular tumour spheroids of colorectal adenocarcinomas--involvement of CD95 pathway and differentiation.

Hauptmann S, Gebauer-Hartung P, Leclere A, Denkert C, Pest S, Klosterhalfen B, Dietel M. Hauptmann S, et al. Among authors: denkert c. Apoptosis. 1998 Sep;3(4):267-79. doi: 10.1023/a:1009613325845. Apoptosis. 1998. PMID: 14646491

9

Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.

Denkert C, Fürstenberg A, Daniel PT, Koch I, Köbel M, Weichert W, Siegert A, Hauptmann S. Denkert C, et al. Oncogene. 2003 Nov 27;22(54):8653-61. doi: 10.1038/sj.onc.1206920. Oncogene. 2003. PMID: 14647459

10

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.

Denkert C, Weichert W, Pest S, Koch I, Licht D, Köbel M, Reles A, Sehouli J, Dietel M, Hauptmann S. Denkert C, et al. Cancer Res. 2004 Jan 1;64(1):189-95. doi: 10.1158/0008-5472.can-03-1987. Cancer Res. 2004. PMID: 14729623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters